Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Molecular Pain|September 14, 2015
Anoctamin-1 Cl(-) channels in nociception: activation by an N-aroylaminothiazole and capsaicin and inhibition by T16A[inh]-A01Farah Deba, Bret F Bessac
Methods in Molecular Biology (Clifton, N.J.)|July 6, 2019
An Animal Model to Test Reversal of Cognitive Decline Associated with Beta-Amyloid PathologiesFarah Deba, Steven Peterson, Ayman K Hamouda
Life Sciences|May 21, 2025
Salvianolic acid-A alleviates oxidative stress-induced osteoporosisAyaan Khan, Hope Sabella, Venkata Kiran Kumar Mandlem, et al.
Molecular Pharmacology|March 16, 2016
Photolabeling a Nicotinic Acetylcholine Receptor (nAChR) with an (α4)3(β2)2 nAChR-Selective Positive Allosteric ModulatorAyman K Hamouda, Farah Deba, Ze-Jun Wang, et al.
The Journal of Biological Chemistry|December 3, 2021
Assessing potentiation of the (α4)3(β2)2 nicotinic acetylcholine receptor by the allosteric agonist CMPIFarah Deba, Kemburli Munoz, Eloisa Peredia, et al.
Frontiers in Pharmacology|September 27, 2024
TLR4 induced TRPM2 mediated neuropathic painVenkata Kiran Kumar Mandlem, Ana Rivera, Zaina Khan, et al.
ACS Applied Bio Materials|January 10, 2022
Re-engineering a Liposome with Membranes of Red Blood Cells for Drug Delivery and Diagnostic ApplicationsColin Ferrel, Sagar Rayamajhi, Tuyen Nguyen, et al.
Neuropharmacology|March 1, 2020
Advances in the In vitro and In vivo pharmacology of Alpha4beta2 nicotinic receptor positive allosteric modulatorsJenny L Wilkerson, Farah Deba, Morgan L Crowley, et al.
Scientific Reports|January 21, 2018
LY2087101 and dFBr share transmembrane binding sites in the (α4)3(β2)2 Nicotinic Acetylcholine ReceptorFarah Deba, Hamed I Ali, Abisola Tairu, et al.
The Journal of Biological Chemistry|April 28, 2017
Unraveling amino acid residues critical for allosteric potentiation of (α4)3(β2)2-type nicotinic acetylcholine receptor responsesZe-Jun Wang, Farah Deba, Tasnim S Mohamed, et al.
Pageof 2